cumulus-neuroscience
Belfast, GB · Founded 2015 · 35 employees on LinkedIn · 3 known investors
Find your way into cumulus-neuroscience
228 people in our graph share verified history with the cumulus-neuroscience team — schools, employers, funds. One of them is your warm intro.
Javier Solterounlockedknows Brian Murphy · together at Carnegie Mellon University (overlapped)
×9knows the team · via Carnegie Mellon University
×2knows the team · via Queen's University Belfast
NeuLogiq is a research platform for clinical trials that integrates tablet-based cognitive assessments, EEG monitoring, and real-world behavioral data to measure brain function changes. The platform serves biopharma sponsors and clinical research sites conducting central nervous system studies across phases 0-3.
Founders & leadership
cumulus-neuroscience was founded in 2015 by Brian Murphy.
BM
Brian MurphyinCo-Founder & CSOBrian Murphy holds education in engineering, cognitive science, computational neuroscience, and machine learning, with prior experience combining startup and research roles. As Co-Founder and Chief Scientific Officer of Cumulus Neuroscience, he applies data science methods to analyze brain activity data and cognitive states from neuroimaging technologies.
T
TinaCEO
Investors · 3
Frequently asked questions
- What does cumulus-neuroscience do?
- NeuLogiq is a research platform for clinical trials that integrates tablet-based cognitive assessments, EEG monitoring, and real-world behavioral data to measure brain function changes. The platform serves biopharma sponsors and clinical research sites conducting central nervous system studies across phases 0-3.
- Who founded cumulus-neuroscience?
- cumulus-neuroscience was founded by Brian Murphy in 2015.
- Who are cumulus-neuroscience's investors?
- cumulus-neuroscience's investors include Dementia Discovery Fund, Clarendon Fund Managers Ltd., LifeArc Ventures.
- Where is cumulus-neuroscience headquartered?
- cumulus-neuroscience is headquartered in Belfast, GB.